In vitro detection of mdr1 mRNA in murine leukemia cells with 111In-labeled oligonucleotide
- PMID: 15449049
- DOI: 10.1007/s00259-004-1666-y
In vitro detection of mdr1 mRNA in murine leukemia cells with 111In-labeled oligonucleotide
Abstract
Purpose: The feasibility of intracellular mdr1 mRNA expression detection with radiolabeled antisense oligonucleotide (ODN) was investigated in the murine leukemia cell line, P388/S, and its subclonal, adriamycin-resistant cell line, P388/R.
Methods: The expression level of mdr1 mRNA was analyzed by reverse transcription-polymerase chain reaction (RT-PCR). Existence of the multidrug resistance (MDR) phenomenon was assessed via cellular uptake of 99mTc-sestamibi (MIBI), a known substrate for P-glycoprotein. A 15-mer phosphorothioate antisense ODN complementary to the sequences located at -1 to 14 of mdr1 mRNA and its corresponding sense ODN were conjugated with the cyclic anhydride of diethylene triamine penta-acetic acid (cDTPA) via an amino group linked to the terminal phosphate at the 5' end at pH 8-9. The DTPA-ODN complexes at concentrations of 0.1-17.4 microM were reacted with 111InCl3 at pH 5 for 1 h. The hybridization affinity of labeled ODN was evaluated with size-exclusion high-performance liquid chromatography following incubation with the complementary sequence. Cellular uptake of labeled ODN was examined in vitro. Furthermore, enhancing effects of synthetic lipid carriers (Transfast) on transmembrane delivery of ODN were assessed.
Results: P388/R cells displayed intense mdr1 mRNA expression in comparison with P388/S cells. 99mTc-MIBI uptake in P388/S cells was higher than that in P388/R cells. Specific radioactivity up to 1,634 MBq/nmol was achieved via elevation of added radioactivity relative to ODN molar amount. The hybridization affinity of antisense 111In-ODN was preserved at approximately 85% irrespective of specific activity. Cellular uptake of antisense 111In-ODN did not differ from that of sense 111In-ODN in either P388/S cells or P388/R cells. However, lipid carrier incorporation significantly increased transmembrane delivery of 111In-ODN; moreover, specific uptake of antisense 111In-ODN was demonstrated in P388/R cells.
Conclusion: Radiolabeling of ODN at high specific radioactivity and specific uptake of antisense 111In-ODN in drug-resistant cells may facilitate future gene imaging of mdr1 mRNA.
Similar articles
-
Binding with serum components favorably affects cellular uptake of 111In-oligonucleotide in a leukemia cell line.Cancer Biother Radiopharm. 2006 Feb;21(1):34-40. doi: 10.1089/cbr.2006.21.34. Cancer Biother Radiopharm. 2006. PMID: 16480329
-
99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells.Ann Nucl Med. 2006 Jan;20(1):29-34. doi: 10.1007/BF02985587. Ann Nucl Med. 2006. PMID: 16485571
-
Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells.Hematology. 2007 Oct;12(5):393-401. doi: 10.1080/10245330701283991. Hematology. 2007. PMID: 17852455
-
Antisense oligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases.Curr Pharm Des. 2004;10(7):797-803. doi: 10.2174/1381612043452965. Curr Pharm Des. 2004. PMID: 15032704 Review.
-
Imaging with radiolabeled antisense oligonucleotides for the detection of intracellular messenger RNA and cardiovascular disease.J Nucl Cardiol. 1999 May-Jun;6(3):345-56. doi: 10.1016/s1071-3581(99)90047-8. J Nucl Cardiol. 1999. PMID: 10385190 Review. No abstract available.
Cited by
-
In vitro characterization of two novel biodegradable vectors for the delivery of radiolabeled antisense oligonucleotides.Cancer Biother Radiopharm. 2010 Dec;25(6):723-31. doi: 10.1089/cbr.2010.0813. Cancer Biother Radiopharm. 2010. PMID: 21204767 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous